These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity. Hu H; Mady Traore MD; Li R; Yuan H; He M; Wen B; Gao W; Jonsson CB; Fitzpatrick EA; Sun D J Med Chem; 2022 Sep; 65(18):12044-12054. PubMed ID: 36070561 [TBL] [Abstract][Full Text] [Related]
3. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19. Hashemian SM; Farhadi T; Velayati AA Drug Des Devel Ther; 2020; 14():3215-3222. PubMed ID: 32821086 [TBL] [Abstract][Full Text] [Related]
6. On the molecular structure of Remdesivir for the treatment of Covid-19. Sheikholeslami SM; Jahanbani A; Shao Z Comput Methods Biomech Biomed Engin; 2021 Jul; 24(9):995-1002. PubMed ID: 33356621 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646 [TBL] [Abstract][Full Text] [Related]
8. Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic. Taha HR; Keewan N; Slati F; Al-Sawalha NA Pharmacology; 2021; 106(9-10):462-468. PubMed ID: 34515227 [TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2. Simonis A; Theobald SJ; Fätkenheuer G; Rybniker J; Malin JJ EMBO Mol Med; 2021 Jan; 13(1):e13105. PubMed ID: 33015938 [TBL] [Abstract][Full Text] [Related]
10. Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir. Pohl MO; Busnadiego I; Marrafino F; Wiedmer L; Hunziker A; Fernbach S; Glas I; Moroz-Omori EV; Hale BG; Caflisch A; Stertz S J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34319869 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2. Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278 [TBL] [Abstract][Full Text] [Related]
12. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Singh AK; Singh A; Singh R; Misra A Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865 [TBL] [Abstract][Full Text] [Related]
13. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962 [TBL] [Abstract][Full Text] [Related]
15. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir. Banerjee A; Kanwar M; Maiti S Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419 [TBL] [Abstract][Full Text] [Related]
16. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19. Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457 [TBL] [Abstract][Full Text] [Related]
17. Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2. Nayeem SM; Sohail EM; Sudhir GP; Reddy MS Eur J Pharmacol; 2021 Jan; 890():173642. PubMed ID: 33065096 [TBL] [Abstract][Full Text] [Related]
18. A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase. Khan S; Attar F; Bloukh SH; Sharifi M; Nabi F; Bai Q; Khan RH; Falahati M Int J Biol Macromol; 2021 Jun; 181():605-611. PubMed ID: 33766591 [TBL] [Abstract][Full Text] [Related]
19. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D Elife; 2021 Oct; 10():. PubMed ID: 34617885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]